Epidermal growth factor receptor (EGFR) targeted therapy in stage III and IV head and neck cancer: guideline recommendations

GUIDELINE TITLE
Epidermal growth factor receptor (EGFR) targeted therapy in stage III and IV head and neck cancer: guideline recommendations.

BIBLIOGRAPHIC SOURCE(S)
Cripps C, Winquist E, Stys-Norman D, Devries M, Gilbert R, Head and Neck Cancer Disease Site Group. Epidermal growth factor receptor (EGFR) targeted therapy in stage III and IV head and neck cancer: guideline recommendations. Toronto (ON): Cancer Care Ontario (CCO); 2009 May 15. 32 p. (Evidence bases series; no. 5-12). [40 references]

GUIDELINE STATUS
This is the current release of the guideline.

The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site for details on any new evidence that has emerged and implications to the guidelines.
http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=44115

abrir aquí para acceder al documento NGC AHRQ completo:
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=15042&nbr=&string=